Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Biosimilars Seen Saving U.S. $54 Billion

An analysis of health care costs shows increasing the use of substitute biologic treatments known as biosimilars could save the United States some $54 billion over 10 years. . . . → Read More: Biosimilars Seen Saving U.S. $54 Billion

Live Skin Bacteria Shown to Control Acne

First results of a clinical trial show a spray-on formulation of live bacteria reduced the amount and severity of acne in people with mild to moderate cases of the condition. . . . → Read More: Live Skin Bacteria Shown to Control Acne

Flashback: Drug Pricing Reform Even Big Pharma Might Like

Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October.

(TBIT/Pixabay)

2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription . . . → Read More: Flashback: Drug Pricing Reform Even Big Pharma Might Like

Trial Comparing 2-D, 3-D Mammogram Outcomes

A large-scale clinical trial is underway comparing the effectiveness of two-dimensional and three-dimensional mammograms in screening for breast cancer. . . . → Read More: Trial Comparing 2-D, 3-D Mammogram Outcomes

Guidelines Designed for CAR T-Cell Cancer Therapies

Cancer specialists and scientists at several cancer care centers propose safety guidelines for patients receiving engineered immune cell treatments that often have severe adverse effects. . . . → Read More: Guidelines Designed for CAR T-Cell Cancer Therapies

FDA Clears First Mobile App for Substance Abuse

A smartphone app designed to help treat substance abuse disorders received approval from the U.S. Food and Drug Administration. . . . → Read More: FDA Clears First Mobile App for Substance Abuse

Trial Shows Antibody Effective Against Asthma

Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma

Risks of E-Cigarette Use, Ingredients Highlighted

Several sessions at a scientific meeting on respiratory diseases report on effects of electronic cigarettes on people’s health, including those who also smoke conventional cigarettes. . . . → Read More: Risks of E-Cigarette Use, Ingredients Highlighted

Engineered T-Cell Trials Stopped after Patient Death

The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died. . . . → Read More: Engineered T-Cell Trials Stopped after Patient Death

Trial Testing Nicotine Patch for Lung Inflammation

A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs. . . . → Read More: Trial Testing Nicotine Patch for Lung Inflammation